Incident heart failure and myocardial infarction in sodium‐glucose cotransporter‐2 vs. dipeptidyl peptidase‐4 inhibitor users

AIMS: This study aimed to compare the rates of major cardiovascular adverse events in sodium‐glucose cotransporter‐2 inhibitors (SGLT2I) and dipeptidyl peptidase‐4 inhibitors (DPP4I) users in a Chinese population. SGLT2I and DPP4I are increasingly prescribed for type 2 diabetes mellitus patients. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jiandong, Lee, Sharen, Leung, Keith Sai Kit, Wai, Abraham Ka Chung, Liu, Tong, Liu, Ying, Chang, Dong, Wong, Wing Tak, Wong, Ian Chi Kei, Cheung, Bernard Man Yung, Zhang, Qingpeng, Tse, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934922/
https://www.ncbi.nlm.nih.gov/pubmed/35132823
http://dx.doi.org/10.1002/ehf2.13830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934922/
https://www.ncbi.nlm.nih.gov/pubmed/35132823
http://dx.doi.org/10.1002/ehf2.13830

Ejemplares similares